Evidence map›Paper›PMID 29593738›Full record

ArticleFrontiers in immunology2018

Prostaglandin E

Yu Zhou, Wei Wang, Conghui Zhao, Yan Wang, Haoming Wu, Xiuyuan Sun, Youfei Guan, Yu Zhang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 59 citations in OpenAlex.

  1. Review
  2. Group 2 innate lymphoid cells: Where are we 15 years out?The Journal of allergy and clinical immunology · 2026
    Review
  3. Linking Lipid Metabolism and Immune Function: New Insights into Chronic Respiratory Diseases.Pathophysiology : the official journal of the International Society for Pathophysiology · 2025
    Review
  4. Review
  5. Review
  6. Endogenous inhibitory mechanisms in asthma.The journal of allergy and clinical immunology. Global · 2023
    Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. ILCs and Allergy.Advances in experimental medicine and biology · 2022
    Article
  16. Crosstalk between ILC2s and Th2 CD4Journal of immunology research · 2022
    Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Yu ZhouDepartment of Immunology, School of Basic Medical Sciences, Peking University Health Science Center, Key Laboratory of Medical Immunology, Ministry of Health (Peking University), Beijing, China.
Wei WangDepartment of Immunology, School of Basic Medical Sciences, Peking University Health Science Center, Key Laboratory of Medical Immunology, Ministry of Health (Peking University), Beijing, China.
Conghui ZhaoDepartment of Oral Pathology, Beijing Stomatological Hospital, Capital Medical University, Beijing, China.
Yan WangDepartment of Immunology, School of Basic Medical Sciences, Peking University Health Science Center, Key Laboratory of Medical Immunology, Ministry of Health (Peking University), Beijing, China.
Haoming WuDepartment of Immunology, School of Basic Medical Sciences, Peking University Health Science Center, Key Laboratory of Medical Immunology, Ministry of Health (Peking University), Beijing, China.
Xiuyuan SunDepartment of Immunology, School of Basic Medical Sciences, Peking University Health Science Center, Key Laboratory of Medical Immunology, Ministry of Health (Peking University), Beijing, China.
Youfei GuanAdvanced Institute for Medical Sciences, Dalian Medical University, Dalian, China.
Yu ZhangDepartment of Immunology, School of Basic Medical Sciences, Peking University Health Science Center, Key Laboratory of Medical Immunology, Ministry of Health (Peking University), Beijing, China.
Peking University · CNCapital Medical University · CNDalian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evidence is accumulating that group 2 innate lymphoid cells (ILC2) play an important role in allergic airway inflammation by producing a large amount of type 2 cytokines. But it remains poorly understood how its activities are properly controlled

Indexed as

AnimalsAsthmaCyclic AMPCytokinesDinoprostoneDisease Models, AnimalGATA3 Transcription FactorHumansImmunity, InnateInterleukin-1 Receptor-Like 1 ProteinInterleukin-33Lymphocyte ActivationLymphocytesMiceMice, Inbred C57BLMice, KnockoutCyclic AMPCytokinesDinoprostoneGata3 protein, mouseGATA3 Transcription FactorIl1rl1 protein, mouseInterleukin-1 Receptor-Like 1 ProteinInterleukin-33Receptors, Prostaglandin E, EP4 Subtypeasthmacyclic adenosine monophosphateE-prostanoid 4group 2 innate lymphoid cellIL-33prostaglandin E2

Identifiers

PMID29593738
PMCPMC5857904
OpenAlexW2790580597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.